THE CORP OF THE TRUSTEES OF THE ORDER OF THE SISTERS OF MERCY IN QUEENSLAND has a total of 12 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are EPIAXIS THERAPEUTICS PTY LTD, IMMUNEMED INC and ABAG.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 12 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Hart Derek Nigel John | 7 |
#2 | Hart Derek | 4 |
#3 | Clark Georgina Jane | 3 |
#4 | Kato Masato | 2 |
#5 | Munster David | 1 |
#6 | Ramirez Jose Alejandro Lopez | 1 |
#7 | Macdonald Kelli Patricia Anne | 1 |
#8 | Vuckovic Slavica | 1 |
#9 | Turtle Cameron John | 1 |
#10 | Hill Geoffrey Roger | 1 |
Publication | Filing date | Title |
---|---|---|
AU2007203611A1 | DCL-1 and uses thereof | |
AU2004285986A1 | Isolated CD4+ T cells defined by CMRF-35 and CD45RO | |
AU2003285994A1 | In vitro immunization | |
AU2003285987A1 | DEC-205 (Ly 75) / DCL-1 intergenic splice variants associated with Hodgkin's disease, and uses thereof | |
AU2003254412A1 | Generation of dendritic cells from cd34+ precursors | |
AU2003254382A1 | A method of characterizing dendritic cells | |
AU2003250592A1 | A method of immunomodulation | |
AU2003249776A1 | A method of immunomodulation | |
AU2002365446A1 | Method for culturing dendritic cells |